Found 13 matching trials
Study of Ozanimod (RPC1063) in Relapsing Multiple Sclerosis (MS)
PHASE3The purpose of this study is to determine whether ozanimod is effective in ...
A Multi-Site, Open-Label Extension Trial of Oral RPC1063 in Relapsing Multiple Sclerosis
PHASE3The purpose of the trial is to determine the safety and efficacy of RPC1063...
Location
Local Institution - 115
Study Describing Cognitive Processing Speed Changes in Relapsing Multiple Sclerosis Subjects Treated With Ozanimod (RPC-1063)
PHASE3This is a multicenter, longitudinal, single-arm, open-label study to descri...
Location
Local Institution - 123
Ulcerative Colitis Leukocyte TRAfficking After Treatment With Zeposia: the ULTRAZ Study
PHASE4The ULTRAZ study is designed to better understand the mode of action of S1P...
Location
Multiple Locations
Efficacy and Safety Study of Ozanimod (RPC1063) in Relapsing Multiple Sclerosis Patients
PHASE2This study is a two-part trial consisting of Part A (presented in this reco...
Location
Alta Bates Summit Medical Center
Multidimensional Integrated Assessment to Test the Efficacy and Response to Ozanimod in Multiple Sclerosis.
PHASE4This is a prospective interventional study with a 12-month follow-up of pat...
Location
IRCCS Fondazione Santa Lucia
Pharmacokinetics and Pharmacodynamics Study of RPC1063 in RMS
PHASE1The purpose of this study is to learn about the pharmacokinetics and pharma...
Location
Breastlink Medical Group, Inc.
A Study to Evaluate the Pharmacokinetics of Single Oral Doses of Ozanimod in Healthy Adult Chinese Subjects
PHASE1This is a Phase 1, open-label, single-dose study. Approximately 24 Chinese ...
Location
Capital Medical University - Beijing Anzhen Hospital
To Evaluate Efficacy and Long-term Safety of Ozanimod in Japanese Subjects With Moderately to Severely Active Ulcerative Colitis
PHASE3Japanese patients with moderate or severe active ulcerative colitis as a su...
Location
Local Institution - 104
Efficacy and Safety Study of Ozanimod in Relapsing Multiple Sclerosis
PHASE3This study is a two-part trial consisting of Part A (see NCT01628393) and P...
Location
Receptos Study Site 115